Cytokinetics director sells $273,634 in shares near 52-week low
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
B. Lynne Parshall, a director at Cytokinetics Inc. (NASDAQ:CYTK), recently sold 5,000 shares of common stock for a total of $273,634. These transactions occurred on November 9, 2026, with share prices ranging from $53.72 to $55.71. Following the sale, Ms. Parshall directly holds 5,784 shares, and the company's stock is currently trading at $56.16, near its 52-week low.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.